Cargando…
New Frontiers in Molecular Imaging Using Peptide-Based Radiopharmaceuticals for Prostate Cancer
The high incidence of prostate cancer (PCa) increases the need for progress in its diagnosis, staging, and precise treatment. The overexpression of tumor-specific receptors for peptides in human cancer cells, such as gastrin-releasing peptide receptor, natriuretic peptide receptor, and somatostatin...
Autores principales: | Li, Xin, Cai, Huawei, Wu, Xiaoai, Li, Li, Wu, Haoxing, Tian, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736158/ https://www.ncbi.nlm.nih.gov/pubmed/33335885 http://dx.doi.org/10.3389/fchem.2020.583309 |
Ejemplares similares
-
(64)Cu-based Radiopharmaceuticals in Molecular Imaging
por: Zhou, Yeye, et al.
Publicado: (2019) -
One-step, kit-based radiopharmaceuticals for molecular SPECT imaging: a versatile diphosphine chelator for (99m)Tc radiolabelling of peptides
por: Hungnes, Ingebjørg N., et al.
Publicado: (2021) -
Targeted Imaging of Tumor-Associated Macrophages by Cyanine 7-Labeled Mannose in Xenograft Tumors
por: Jiang, Chong, et al.
Publicado: (2017) -
Developments in (177)Lu-based radiopharmaceutical therapy and dosimetry
por: George, Siju C., et al.
Publicado: (2023) -
Radiosynthesis, quality control, biodistribution, and infection-imaging study of a new (99m)Tc-labeled ertapenem radiopharmaceutical
por: Naqvi, Syed Ali Raza, et al.
Publicado: (2022)